The future is Aristotle , not Covid testing.There has been so much emphasis on the 3rd quarter revenue generated by Covid testing that a lot of people have lost focus of the main objective of the company .
Covid testing has very conveniently generated cash flow for the company , and from the looks of it , it could very well turn out to be substantial cash in the near future .
Most of the revenue generated should go towards the launch of Aristotle , which by the way seems to be on schedule and that is great news.
Why is it great news ? Because until Aristotle launch is confirmed , the institutions will be on the sidelines as Covid testing is not a viable long term business model , Cancer prevention is .
Which leads us the SP , it is being manipulated ? My guess is yes , it is being held down to allow institutions to buy the shares cheap once the go ahead is confirmed .
So to those who are holding shares and warrants , unless you have access to the latest public offering , do not sell anything , the future looks very bright.
Cheers to all